MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

Similar documents
508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

The influence of societal individualism on a century of tobacco use: modelling the prevalence of smoking Appendices A and B

CARDIOVASCULAR DISEASE AND DIABETES:

Outcomes of Health Systems : Towards the development of indicators of amenable mortality

Changes in Subjective Well-Being and Their Implications

Progress report on the analysis of cancer care

OECD Family database OECD - Social Policy Division - Directorate of Employment, Labour and Social Affairs

PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK

Allied Health: Sustainable Integrated Health Care for all Australians

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SERBIA

Paradoxes of well-being

Fertility in OECD countries: An assessment of macro-level trends and policy responses

Indicators of suicide among people with serious mental illness

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Smokefree Policies in Europe: Are we there yet?

The relationship between trust, cognitive skills, and democracy - evidence from 30 countries around the world

The health economic landscape of cancer in Europe

Overview of drug-induced deaths in Europe - What does the data tell us?

Aldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato Urso, Niek Klazinga, Roberto Ferrari, Nikolaos Maniadakis and Luigi Tavazzi.

Assessment of PM2.5 concentrations

LEBANON. WCPT COUNTRY PROFILE December 2018

Louisville '19 Attachment #69

DENMARK. WCPT COUNTRY PROFILE December 2018

GERMANY. WCPT COUNTRY PROFILE December 2018

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care

Differences make a Difference

The Urgency of the Situation: The Cost of Childhood Obesity for Society

PLACEMENT AND TREATMENT OF MENTALLY ILL OFFENDERS LEGISLATION AND PRACTICE IN EU-MEMBER STATES

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

European Collaboration on Dementia. Luxembourg, 13 December 2006

Access to treatment and disease burden

Main developments in past 24 hours

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Johns Hopkins individualized Health Initiative

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

The OECD Health Care Quality Indicators Project

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Cross Border Genetic Testing for Rare Diseases

BioPlex 2200 Infectious Disease Panels

Engagement in language assessment / Regions of Europe

World Connections Committee (WCC) Report

The impact of pharmaceutical innovation on mortality, disability, and hospitalization:

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Terms and Conditions. VISA Global Customer Assistance Services

CND UNGASS FOLLOW UP

Where we stand in EFORT

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank

The Risk of Alcohol in Europe. Bridging the Gap June 2004

Where do EU Contries set the limit for low risk drinking.

All about interrai. Len Gray Coordinator, interrai Network of Excellence in Acute Care April

Immunohematology. IH-QC Modular System. Select. Combine. Control.

Alcohol-related harm in Europe and the WHO policy response

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Q1 What age are you?

Appendix F: Test-Curriculum Matching Analysis

The Influence of Equating Methodology on Reported Trends in PISA

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

Prof. Renata Cífková, MD, CSc.

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

Monthly measles and rubella monitoring report

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

The OECD Guidelines on Subjective Well-Being

Rheumatoid Arthritis Disease Burden and Access to Treatment

Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Overview of European Consumption Databases

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

Real Life, Real PD Survey

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance

EUROPEAN AEROSOL PRODUCTION

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

Milk consumption in relation to incidence of nasopharyngeal carcinoma in 48 countries/regions

European Status report on Alcohol and Health

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

The cancer burden in the European Union and the European Region: the current situation and a way forward

Global EHS Resource Center

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers NZ & Australia

Transcription:

MENTAL HEALTH CARE OECD HCQI Expert meeting 17 th of May, 2013 Rie Fujisawa

Mental health indicators Any hospital readmissions for patients with schizophrenia Same hospital readmissions for patients with schizophrenia Any hospital readmissions among patients with schizophrenia Same hospital readmissions among patients with schizophrenia Any hospital readmissions for patients with bipolar disorder Same hospital readmissions for patients with bipolar disorder Any hospital readmissions among patients with bipolar disorder Same hospital readmissions among patients with bipolar disorder Inpatient death from suicide among patients admitted at the hospital for a mental disorder In-patient death from suicide among patients admitted at the hospital for schizophrenia or bipolar disorder Death from suicide among patients discharged with a mental disorder Death from suicide among patients discharged with schizophrenia or bipolar disorder Excess mortality from schizophrenia Excess mortality from bipolar disorder 2

Data submission Data submitted by 16 OECD and 1 non-oecd countries (BEL, CAN, CZE, FIN, HUN, ISR, ITA, KOR, LUX, NZL, PRT, SVK, ESP, SWE, CHE, GBR and LVA). Data are not available in AUT, FRA, GRC, ISL, JPN, NLD, POL and TUR. Validating data for CHL, IRL, NOR and SVN. Waiting for data from AUS, DEU and USA. No news from DNK, EST and MEX. 3

Countries MENTAL HEALTH CARE AVERSCHA AVERSCHS ADMRSCHA ADMRSCHS AVERBIPA AVERBIPS ADMRBIPA ADMRBIPS SUICMENT SUICSEME MORTSUMD MORTSUMD EXCESCHI EXCEBIPO Australia Austria............................ Belgium.. 2010.. 2010.. 2010.. 2010 2010 2010........ Canada................ 2011 2011........ Chile 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 Czech Republic 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011.... Denmark Estonia Finland 2011 2011.... 2011 2011.... 2011 2011 2011 2011 2011 2011 France............................ Germany Greece............................ Hungary 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012........ Iceland............................ Ireland Israel 2012 2012 2012 2012 2012 2012 2012 2012 2009 2009 2009 2009 2009 2009 Italy 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011........ Japan............................ Korea 2011 2011 2011 2011 2011 2011 2011 2011........ 2011 2011 Luxembourg........ 2011 2011................ Mexico Netherlands............................ New Zealand 2011 2011 2011 2011 2011 2011 2011 2011 2010 2010 2010 2010 Norway 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011........ Poland............................ Portugal 2011 2011 2011 2011 2011 2011 2011 2011............ Slovak Republic 2011 2011.... 2011 2011.... 2011 2011........ Slovenia................ 2011 2011 2011 2011.... Spain.. 2011.. 2011.. 2011.. 2011 2011 2011........ Sweden 2011 2011 2011 2011 2011 2011 2011 2011.... 2011 2011 2011 2011 Switzerland 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010........ Turkey United Kingdom 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011.... USA Singapore............................ Brazil Latvia.................... 2011 2011 2011.. 4

Proposals for HAG 2013 Hospital re-admissions within 30 days Mortality 5

Same and any hospital re-admissions within 30 days for patients discharged with schizophrenia, 2006 and 2011 (preliminary) Portugal Spain Korea Israel Sweden New Zealand Italy United Kingdom Hungary Belgium Switzerland Czech Republic Finland Slovak Republic 0.42 0.35 0.33 0.30 0.31 0.22 0.15 0.16 0.13 0.09 0.08 1.58 Same hospital (2011) Any hospital (2011) Any hospital (2006) -1.0 0.0 1.0 2.0 3.0 4.0 Per patient Notes: 2011 data on Belgium and Switzerland refer to 2010. 2006 data refer to 2007 for Korea and the United Kingdom, 2008 for Sweden and 2009 for the Czech Republic and Portugal. 6

Any hospital re-admissions within 30 days for patients discharged with schizophrenia by gender, 2011 (preliminary) Portugal 1.39 Korea 0.40 Israel 0.34 New Zealand 0.29 Italy 0.31 Sweden United Kingdom Switzerland 0.22 0.13 0.39 Female Male Hungary 0.15 Czech Republic 0.12 Finland 0.09 Slovak Republic 0.08-0.5 0.0 0.5 1.0 1.5 2.0 2.5 Notes: Data on Switzerland refer to 2010. Per patient 7

Same and any hospital re-admissions within 30 days among patients discharged with schizophrenia, 2006 and 2011 (preliminary) Israel 22.0 Korea 22.7 Sweden 17.1 New Zealand 19.0 Belgium Spain Italy 17.5 United Kingdom 13.5 Hungary Czech Republic Switzerland Portugal 1.7 9.4 10.8 10.4 Same hospital (2011) Any hospita (2011) Any hospital (2006) 0 5 10 15 20 25 30 % of patients Notes: 2011 data on Belgium and Switzerland refer to 2010. 2006 data refer to 2007 for Korea, 2008 for Sweden and the United Kingdom and 2009 for the Czech Republic. 8

% of Patients with readmissions within 30 days Any hospital readmissions within 30 days per patient and % of patients with any hospital readmissions within 30 days, schizophrenia, 2011 (preliminary) 25 20 15 KOR ISR NZL SWE ITA GBR 10 HUN CZE CHE 5 PRT 0 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 Number of readmissions within 30 days per patient Notes: Data on Switzerland refer to 2010. 9

Same and any hospital re-admissions within 30 days for patients discharged with bipolar disorder, 2006 and 2011 (preliminary) Portugal Spain Sweden Israel United Kingdom New Zealand Korea Italy Belgium Switzerland Czech Republic Hungary Finland Slovak Republic 0.29 0.30 0.24 0.26 0.19 0.26 0.15 0.12 0.09 0.09 0.07 2.14 Same hospital (2011) Any hospital (2011) Any hospital (2006) -0.5 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 Per patient Notes: 2011 data on Belgium and Switzerland refer to 2010. 2006 data refer to 2007 for Korea and the United Kingdom, 2008 for Sweden and 2009 for the Czech Republic and Portugal. 10

Same and any hospital re-admissions within 30 days among patients discharged with bipolar disorder, 2006 and 2011 (preliminary) Israel 19.9 Sweden 17.8 New Zealand 17.8 Belgium Spain United Kingdom 14.1 Korea 12.6 Italy 16.0 Czech Republic Switzerland Hungary 7.2 9.6 10.4 Same hospital (2011) Any hospita (2011) Portugal 1.0 Any hospital (2006) 0 5 10 15 20 25 30 % of patients Notes: 2011 data on Belgium and Switzerland refer to 2010. 2006 data refer to 2007 for Korea, 2008 for Sweden and the United Kingdom and 2009 for the Czech Republic. 11

% of Patients with readmissions within 30 days Any hospital readmissions within 30 days per patient and % of patients with any hospital readmissions within 30 days, bipolar disorder, 2011 (preliminary) 25 20 15 10 5 ISR NZL SWE ITA GBR KOR CZE CHE HUN PRT 0 0.0 0.5 1.0 1.5 2.0 2.5 Number of readmissions within 30 days per patient Notes: Data on Switzerland refer to 2010. 12

Proposals for HAG 2013 Hospital re-admissions within 30 days Same hospital readmissions for patients with schizophrenia, 2006 and 2011 Same hospital readmissions among patients with schizophrenia, 2006 and 2011 Same hospital readmissions for patients with bipolar disorder, 2006 and 2011 Same hospital readmissions among patients with bipolar disorder, 2006 and 2011 13

Mortality: In-patient death from suicide among patients admitted at the hospital for a mental disorder, 2006 and 2011 (preliminary) Finland 0.07 Canada 0.06 Israel 0.06 United Kingdom 0.05 Slovak Republic 0.05 New Zealand 0.03 Hungary 0.03 Switzerland 0.02 Male (2011) Spain Belgium Czech Republic Italy 0.00 0.00 0.02 0.02 Female (2011) Total (2011) Total (2006) -0.05 0.00 0.05 0.10 0.15 Age -sexstandardised rates (%) Notes: 2011 data refer to 2010 for Belgium, New Zealand and Switzerland and 2009 for Israel, and 2006 data refer to 2008 for the United Kingdom. 14

Mortality: In-patient death from suicide among patients admitted at the hospital for schizophrenia or bipolar disorder, 2006 and 2011 (preliminary) New Zealand United Kingdom Finland Slovak Republic Israel Canada Switzerland Spain Belgium Hungary Italy Czech Republic 0.09 0.08 0.06 0.05 0.04 0.04 0.04 0.02 0.02 0.01 0.00 0.00 Male (2011) Female (2011) Total (2011) Total (2006) -0.1 0.0 0.1 0.2 0.3 Age-sex standardised rates (%) Notes: 2011 data refer to 2010 for Belgium, New Zealand and Switzerland and 2009 for Israel, and 2006 data refer to 2008 for the United Kingdom. 15

In-patient deaths from suicide, schizophrenia or bipolar disorder (%) In-patient death from suicide among patients admitted at the hospital for a mental disorder, and schizophrenia or bipolar disorder, 2011 (preliminary) 0.06 0.05 0.04 CHE SVK ISR CAN 0.03 0.02 0.01 BEL ESP HUN CZE 0.00 ITA 0.00 0.01 0.02 0.03 0.04 0.05 0.06 In-patient deaths from suicide, mental disorders (%) Notes: Data refer to 2010 for Belgium, New Zealand and Switzerland and 2009 for Israel. 16

Mortality: Death from suicide among patients discharged with a mental disorder, 2006 and 2011 (preliminary) Sweden 0.33 Finland 0.26 Israel 0.24 New Zealand 0.20 Male (2011) Czech Republic United Kingdom 0.06 0.17 Female (2011) Total (2011) Total (2006) 0.0 0.1 0.2 0.3 0.4 0.5 0.6 Age -sex standardised rates (%) Notes: 2011 data refer to 2010 for New Zealand and 2009 for Israel, and 2006 data refer to 2008 for Sweden and the United Kingdom. 17

Mortality: Death from suicide among patients discharged with schizophrenia or bipolar disorder, 2006 and 2011 (preliminary) Sweden 0.37 Israel 0.27 New Zealand 0.23 Finland 0.18 Male (2011) Czech Republic United Kingdom 0.14 0.13 Female (2011) Total (2011) Total (2006) -0.1 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 Age-sex standardised rates (%) Notes: 2011 data refer to 2010 for New Zealand and 2009 for Israel, and 2006 data refer to 2008 for Sweden and the United Kingdom. 18

Deaths from suicide, schizophrenia or bipolar disorder (%) Mortality: Death from suicide among patients discharged with a mental disorder or schizophrenia or bipolar disorder, 2011 (preliminary) 0.4 SWE 0.3 0.2 NZL ISR FIN 0.1 GBR CZE 0.0 0.0 0.1 0.2 0.3 0.4 Deaths from suicide, mental disorders (%) Notes: Data refer to 2010 for New Zealand and 2009 for Israel. 19

Mortality: Excess mortality from schizophrenia, 2006 and 2011 (preliminary) Sweden 6.80 Finland 4.00 Israel Korea 3.30 3.10 Male (2011) Female (2011) Total (2011) Total (2006) 0 2 4 6 8 10 Ratio Notes: 2011 data refer to 2009 for Israel, and 2006 data refer to 2007 for Korea and 2008 for Sweden. 20

Mortality: Excess mortality from bipolar disorder, 2006 and 2011 (preliminary) Sweden 8.80 Israel 6.80 Finland 6.00 Male (2011) Female (2011) Korea 3.60 Total (2011) Total (2006) 0 2 4 6 8 10 12 Ratio Notes: 2011 data refer to 2009 for Israel, and 2006 data refer to 2007 for Korea and 2008 for Sweden. 21

Proposals for HAG 2013 Mortality Death from suicide among patients discharged with a mental disorder, 2006 and 2011 Death from suicide among patients discharged with schizophrenia or bipolar disorder, 2006 and 2011 Excess mortality from schizophrenia, 2006 and 2011 Excess mortality from bipolar disorder, 2006 and 2011 22